(Q41724223)

8 October 2017

1 reference

title

New developments in cardiovascular adrenergic receptor pharmacology: molecular mechanisms and clinical relevance (English)

1 reference

8 October 2017

Smiley RM

1

1 reference

8 October 2017

Kwatra MM

series ordinal

2

1 reference

8 October 2017

Schwinn DA

series ordinal

3

1 reference

8 October 2017

publication date

1 February 1998

1 reference

Journal of Cardiothoracic and Vascular Anesthesia

8 October 2017

published in

1 reference

8 October 2017

volume

12

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

80-95

1 reference

Adrenoceptors and their second messenger systems

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta 3-adrenoceptors in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Functional beta3-adrenoceptor in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Specific atrial overexpression of G protein coupled human beta 1 adrenoceptors in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Central hypotensive effects of the alpha2a-adrenergic receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Model systems for the study of seven-transmembrane-segment receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Structural basis of beta-adrenergic receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Structure, function, and regulation of adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Adrenoceptors as models for G protein-coupled receptors: structure, function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Structure and function of G protein coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

1 reference

7 January 2021

Diversity of G proteins in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

New roles for G-protein beta gamma-dimers in transmembrane signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Isolation of cDNA Clones Encoding Eight Different Human G Protein γ Subunits, Including Three Novel Forms Designated the γ4, γ10, and γ11 Subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Primary structure of a gamma subunit of G protein, gamma 12, and its phosphorylation by protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Regional distribution of ?1- and ?2-adrenoceptors in the failing and nonfailing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Receptor redistribution does not accompany terbutaline-induced down regulation of beta-adrenergic receptors on human mononuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

G protein-coupled receptor kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenergic receptor kinase: primary structure delineates a multigene family

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

A novel G protein-coupled receptor kinase gene cloned from 4p16.3

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Control of receptor sensitivity at the mRNA level

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Physician use of beta-adrenergic blocking therapy: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alpha 2-adrenergic agonists in cardiovascular anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Neurohormonal interactions and adaptations in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenoceptors in cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Mechanisms of beta adrenoceptor desensitisation in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Reduced beta 1 receptor messenger RNA abundance in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Cardiac chamber-specific beta-adrenoceptor regulation and sympathetic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Autoradiographic localization and quantitation of beta 1- and beta 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Lymphocyte G proteins reflect response to treatment in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Increased levels of inhibitory G protein in myocardium with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-blockers in heart failure: promising or proved?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

The paradox of beta-adrenergic blockade for the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-blockers in heart failure: a therapeutic paradox

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Use of beta-adrenoceptor blockers in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-blockers and sudden cardiac death.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Externalization of beta-adrenergic receptors promoted by myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Characteristics of the beta-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Effects of bucindolol in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Vasodilating beta-blockers in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Sotalol: a novel beta-blocker with class III anti-arrhythmic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Comparison of class I and class III action in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

1 reference

7 January 2021

Efficacy of sotalol in controlling reentrant supraventricular tachycardias.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Efficacy and safety of sotalol in patients with complex ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Controlled trial of sotalol for one year after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

The metabolic response to stress: an overview and update

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

beta Adrenergic receptor desensitisation may serve a cardioprotective role

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Epidural anesthesia and analgesia in high-risk surgical patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Decreased myometrial beta-adrenoceptors in women receiving beta 2-adrenergic tocolytic therapy: correlation with lymphocyte beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Human Lymphocytes as a Model for Beta-Adrenergic Receptors in Clinical Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenergic receptor function is acutely altered in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Platelet alpha-adrenergic receptors are not down-regulated during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Cardiac Surgery Causes Desensitization of the β-Adrenergic Receptor System of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Down-regulation and desensitization of the beta-adrenergic receptor system of human lymphocytes after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alterations of the beta-adrenergic receptor system after thoracic and abdominal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Lymphocyte beta 2-adrenoceptors and adenosine 3':5'-cyclic monophosphate during and after normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Lymphocyte beta 2-adrenoceptor density during menstrual cycle and pregnancy, in delivery and puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

The chronotropic effect of isoproterenol is reduced in term pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Changes in lymphocyte beta 2-adrenoceptors after hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass. Evidence for early uncoupling and late downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Uncoupling of human cardiac beta-adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Myocardial β-Adrenergic Receptor Function and High-Energy Phosphates in Brain Death– Related Cardiac Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Beta adrenoceptor density in the donor heart: a guide to prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alpha 2-adrenergic agents in anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Correlation between human myometrial and platelet alpha 2-adrenoceptor density

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Four consecutive serines in the third intracellular loop are the sites for beta-adrenergic receptor kinase-mediated phosphorylation and desensitization of the alpha 2A-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Renal alpha-adrenergic receptors and genetic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Down-regulation of alpha 2-adrenoceptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Alpha 2-adrenoceptors: more subtypes but fewer functional differences.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Endotoxin disrupts beta-adrenergic signal transduction in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Characterization of cardiac beta-adrenergic receptors in the guinea pig heart: application to study of beta-adrenergic receptors in shock models

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Burn injury alters beta-adrenergic receptor and second messenger function in rat ventricular muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

PET receptors. Counting receptors using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-0770%2898%2990062-3

7 January 2021

10.1016/S1053-0770(98)90062-3

Identifiers

DOI

1 reference

release_wbnfh2iy2vak5fagm3yce76le4

8 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wbnfh2iy2vak5fagm3yce76le4

24 November 2022

mapped directly with Wikidata item

1 reference